The study says that sweet stuff wakes up Bacteria in taking up medicine. A spoon of sugar taken with the medicine, not only makes the swallowing of medicine easy, it increases the potency of the medicine.
The results of the study show that Sugar can make some antibiotics more effective in decreasing the Bacterial Infections.
The researcher says that addition of Sugar to medication may not be good for some dangerous Bacterial Infections including Tuberculosis and Staph etc.
Prostate Cancer is increasing day by day. Many people are suffering from this disease and deciding about the treatment of Prostate Cancer can be difficult because the options available today are better than they were 10 years ago and they are also not very reliable data is available to make the decisions for the treatment. The researchers are still making discoveries to compare the benefits and risks for various treatments for this Cancer
It is a condition in which the Stool becomes Green in color or it has a Greenish touch. It is considered as an abnormal condition in the Humans but it is considered normal for the Infants who are nourished on Breast Milk.
Green Poop is a condition which is common among Children and Adults all over the World.
If you are passing Green Stools, it means you are suffering from Stress, you have abnormal intake of food like consuming food dyes, food colors, Iron supplements, medicines and Green Vegetables etc.
An electronic health record (EHR) stores all of an individual patient’s information in electronic format. The record is maintained by the provider over time and may include the patient’s medical history, current medications, demographics, doctor’s notes and other important administrative information. Issues concerning EHRs include data exchange, privacy and security, and patient consent. The final rule for Meaningful Use, released on July 13, 2010, allows hospitals to qualify for thousands of dollars in stimulus funding for the adoption of electronic health records
.
Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm – which causes a rare but life-threatening disease in humans – dead in its tracks. The report, which appears in ACS’ Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.
Carsten Vock, Andrew Hemphill and colleagues explain that alveolar echinococcosis (AE) is a parasitic disease caused by the fox tapeworm Echinococcus multilocularis. Although rare, AE disease results in the death of about 94 percent of patients worldwide within 10-20 years of diagnosis if not treated appropriately. Most infections occur in the Northern hemisphere, in places like central Asia, northwestern China, and parts of Japan and Europe. People become infected from eating food contaminated with the parasite’s eggs, which are found in the feces of infected foxes, cats or dogs. Surgery is the best option for AE patients, but it does not always remove all of the parasites. Current AE drugs do not cure the disease, but simply keep the parasites at bay. These medicines must be taken life-long. In AE patients, the tapeworms cause tumor-like growths, which can metastasize or spread to different parts of the body. This reminded the researchers of cancer, so they looked at whether ruthenium complexes, promising anti-cancer agents, could also treat tapeworm.
The group prepared and evaluated several ruthenium complexes as potential drugs against the fox tapeworm. Some were effective in killing the tapeworms and also were less toxic on normal cells in laboratory dish tests, making them prime candidates for further development as treatments for AE.
Being able to make a tremendous difference in the lives of cancer patients, combined with being at the forefront of exciting new scientific discoveries, is what new oncology nurses can expect if they choose this profession.
It is a rewarding career path that has offered opportunities to transform care and improve the quality of life for patients with cancer, according to oncology nurse Paula Trahan Rieger, RN, MSN, AOCN, FAAN, former chief executive officer of the Oncology Nursing Society (ONS).
Rieger, who spent more than 20 years as a nurse practitioner in the Department of Clinical Cancer Prevention, Human Clinical Cancer Genetics Program at the University of Texas MD Anderson Cancer Center, in Houston, offers advice to nursing students and new graduates interested in pursuing a career in oncology nursing.
What do you enjoy most about being an oncology nurse?
The ability to work in a specialty that allows nurses to make a tremendous difference in the lives of patients and families, and one that is in the midst of exciting scientific discoveries that will change the way we think about the management of cancer.
What can a new oncology nurse expect in the first few months or the first year on the job?
The new nurse can expect a time of intense learning as he or she begins to apply the skills and knowledge learned in formal training.
What is the most challenging part of the role of oncology nurse?
The most challenging part is being able to keep up with the many changes and new discoveries in cancer care. Learning to balance and keep in perspective both the joys and sadness of working with patients and families in the continuum of cancer care also can be challenging.
What is one critical piece of advice you would offer a nursing student or new graduate interested in pursuing a career as an oncology nurse?
Look for a good mentor—one that can help you along in your new career, in navigating the challenges of a first year in practice, and one that can open the door to the many professional opportunities that await you.
What are the important steps to take to prepare for the oncology nurse career path?
Find a job that will support professional practice and the opportunity to seek continuing education that will provide a basic foundation in oncology. Join a professional society, such as ONS, that will provide educational opportunities, access to leadership training and opportunities, as well as a professional network.
For more information, visit the Web site of the Oncology Nursing Society, an organization of more than 35,000 health care professionals dedicated to advancing cancer care.
Refference:
The scenario is one of a patient’s worst nightmares: They go into the hospital for surgery and leave with a lot more than they bargained for–a foreign object left inside the surgical site. Left unnoticed, it could result in numerous medical complications, including infection, bowel perforation, abscess, undue pain, return to surgery and even death.
“It is estimated that 1,500 to 2,000 retained surgical item (RSI) incidents–where an object like a sponge or gauze is left inside a patient after a surgical procedure–occur each year in the United States. It is a dangerous, and often very costly, medical error,” explained Jeffrey Port, M.D., associate professor of cardiothoracic surgery and associate attending surgeon in the division of thoracic surgery at New York Presbyterian-Weill Cornell Medical Center in New York City.
Jeffrey Port, M.D., founder of RF Surgical Systems, reported that between 1,500 – 2,000 incidents of retained surgical items (RSIs) occur ever year in the United States.
“According to The Joint Commission, objects accidentally left inside a patient during surgery is among the top 10 sentinel events reported,” Port continued. “The number of RSIs nearly doubled in 2010 compared with 2008.”
With The Joint Commission’s continued focus on patient safety and the investigation of sentinel events, as well as payers’ denial of reimbursement for hospital-acquired conditions, prevention of RSIs has become even more critical. New technology has been developed to enhance clinicians’ ability to mitigate the risk of surgical instrument retention and protect patient safety.
“Combining standardized counting procedures with technology and improving communication are key processes for prevention of RSI,” explained Lisa Spruce, RN, DNP, director, evidence-based perioperative practice, with the Association of preoperative Nurses (AORN). “We have been using radiological verification for years to detect radiopaque soft goods and instruments. Today we have radiofrequency detection technology that can detect radiofrequency-tagged material that is used inside the patient. When a patient is scanned using this technology it will alert the surgical team that an item has remained inside the patient.”
One such technology is the RF Assure Detection System, developed by Bellevue, Washington-based RF Surgical Systems, Inc., which Port founded.
The RF Assure Detection System features an automatic detection mat for “hands-free” patient scanning that can speed up searches and verify a nurse’s count of surgical items.
“The RF Assure Detection System helps to eliminate the risk of an RSI by serving as an added verification and security for manual counting of surgical materials by OR staff,” Port explained. “The surgical count is an important process in the OR, but it’s one that can sometimes be compromised by distraction, multitasking, time limitations and human error–especially in bariatric, cardiac or trauma cases where risk for RSIs is higher.”
HOW IT WORKS?
ü RF Surgical Detection Technology uses a low energy radio frequency signal capable of locating misplaced surgical items prior to wound closure through blood, dense tissue, bone and performs well near metals.
Benefits of the RF Surgical Detection System.
EASE OF USE
STAFF SAFETY & CONFIDENCE
ACCURACY & RELIABILITY
COST EFFECTIVE
ECO FRIENDLY
ü Reusable Blair-Port wand and RF Assure Detection mat reduces waste in landfills.
Technology Reducing the Risk of Retained Surgical Instruments
The scenario is one of a patient’s worst nightmares: They go into the hospital for surgery and leave with a lot more than they bargained for–a foreign object left inside the surgical site. Left unnoticed, it could result in numerous medical complications, including infection, bowel perforation, abscess, undue pain, return to surgery and even death.
“It is estimated that 1,500 to 2,000 retained surgical item (RSI) incidents–where an object like a sponge or gauze is left inside a patient after a surgical procedure–occur each year in the United States. It is a dangerous, and often very costly, medical error,” explained Jeffrey Port, M.D., associate professor of cardiothoracic surgery and associate attending surgeon in the division of thoracic surgery at New York Presbyterian-Weill Cornell Medical Center in New York City.
Jeffrey Port, M.D., founder of RF Surgical Systems, reported that between 1,500 – 2,000 incidents of retained surgical items (RSIs) occur ever year in the United States.
“According to The Joint Commission, objects accidentally left inside a patient during surgery is among the top 10 sentinel events reported,” Port continued. “The number of RSIs nearly doubled in 2010 compared with 2008.”
With The Joint Commission’s continued focus on patient safety and the investigation of sentinel events, as well as payers’ denial of reimbursement for hospital-acquired conditions, prevention of RSIs has become even more critical. New technology has been developed to enhance clinicians’ ability to mitigate the risk of surgical instrument retention and protect patient safety.
“Combining standardized counting procedures with technology and improving communication are key processes for prevention of RSI,” explained Lisa Spruce, RN, DNP, director, evidence-based perioperative practice, with the Association of preoperative Nurses (AORN). “We have been using radiological verification for years to detect radiopaque soft goods and instruments. Today we have radiofrequency detection technology that can detect radiofrequency-tagged material that is used inside the patient. When a patient is scanned using this technology it will alert the surgical team that an item has remained inside the patient.”
One such technology is the RF Assure Detection System, developed by Bellevue, Washington-based RF Surgical Systems, Inc., which Port founded.
The RF Assure Detection System features an automatic detection mat for “hands-free” patient scanning that can speed up searches and verify a nurse’s count of surgical items.
“The RF Assure Detection System helps to eliminate the risk of an RSI by serving as an added verification and security for manual counting of surgical materials by OR staff,” Port explained. “The surgical count is an important process in the OR, but it’s one that can sometimes be compromised by distraction, multitasking, time limitations and human error–especially in bariatric, cardiac or trauma cases where risk for RSIs is higher.”
HOW IT WORKS?
ü RF Surgical Detection Technology uses a low energy radio frequency signal capable of locating misplaced surgical items prior to wound closure through blood, dense tissue, bone and performs well near metals.
Benefits of the RF Surgical Detection System.
EASE OF USE
STAFF SAFETY & CONFIDENCE
ACCURACY & RELIABILITY
COST EFFECTIVE
ECO FRIENDLY
ü Reusable Blair-Port wand and RF Assure Detection mat reduces waste in landfills.
One in three individuals will continue to accumulate blood in the brain from a leak in a small artery. Pooling blood in the brain has serious consequences, and could lead to disability or even death. Previously, doctors in emergency stroke situations could not discern whether or not a patient’s brain bleeding had stopped. Using CT scan images, researchers can now identify “spot signs” that are seen as a small area of contrast on the CT scan. This spot sign is the actual location of bleeding within an artery in the brain.
“Technology that has emerged has allowed us to see the brain’s blood flow system in exquisite detail to precisely identify the source of the problem,” explains Dr. Andrew Demchuk, Professor in the departments of clinical neurosciences and radiology, and lead author of this study. “We are now at a point where we can harness this technology to develop better treatments for patients with a blockage or breakage in a brain artery. Ultimately this research will confirm when immediate treatment is necessary — essentially, as soon as you see the spot sign.”
This research provides validation of a new imaging marker to identify patients that may need to be treated with clotting medications versus those that don’t. “We must be very careful when and to whom these drugs are administered because they are so powerful at forming clots. These drugs can cause clots not only where there are holes and leaks — but also in intact arteries -potentially causing stroke and heart attacks,” says Demchuk. “Therefore this CT scan selection is critical for targeting only those patients at highest risk of continued bleeding.”
Clinical trials have now begun to test powerful clotting drugs in these patients.
This University of Calgary-led “PREDICT” study was coordinated with researchers at the Universities of Ottawa and Toronto, along with collaboration amongst nine other centres around the world. Their results were published in the March 8th online edition of the journal Lancet Neurology.
hicinformaticsworthylore 